Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” J. Pharma. Anal. 11 (2021) 265–271

摘要

SARS-CoV-2 shares many of the same characteristics as most coronavirus family viruses, including a pleomorphic or spherical shaped capsid envelope 150e160 nm in size, a polycistronic mRNA with a 50 cap and 30 poly-A-tail, and an unsegmented, positive, single-stranded RNA genome (30 kb) 32e34. SARS-CoV-2 has two large polyproteins, ORF1a and ORF1b; four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N); and eight accessory proteins: ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8a, ORF8b, and ORF9b.